Table 1.

The timeline of the patient’s clinical presentations and paraclinical findings during both admissions and follow-up period

Date	Day	Clinical description	Eosinophilia	STE (GLS) (%)	Bull’s eye (W&W)	LVEF by 2DE (%)	CMR
18.04.2019 (first admission)	1	Fever, dyspnea, hypotension	Significantly positive	− 4.1	Reduced LS (all segments)	9.0
23.04.2019	3–5	No more fever, less dyspnea	Getting better, None on the 5th day	− 8.4	Present	24.0	Acute inflammation (severe LGE)
27.04.2019	9	Doing much better	Absent	− 12.1	Present	31.0
07.05.2019	19	Doing well	Absent	− 13.9	Present	38
03.07.2019	76	No symptoms	Absent	− 17.1	Present	48.0
Treatment non-compliance leading to disease recurrence
18.07.2019 (second admission)	91	Fever, dyspnea	Present but less than the first admission	− 10.4	Reduced LS mainly in the base, mid and apical regions	24.0
25.07.2019	98	Feeling much better	Absent	− 14.6	Present	39	Subendocardial and epicardial edema
19.09.2019	153	Doing well	Absent	− 12.9	Present	38.0	Small areas of residual inflammation and scar formation
20.11.2019	216	No symptoms	Absent	− 15.8	Present	48.0
21.01.2020	278	No symptoms	Absent	− 13.2	Present	42.0
25.04.2020	373	No symptoms	Absent	− 14.6	Present	45.0

CMR cardiac magnetic resonance, GLS global longitudinal strain, LS longitudinal strain, LVEF left ventricular ejection fraction, STE speckle tracking echocardiography, 2DE two-dimensional echocardiography, W&W wax and wanes